Literature DB >> 19702489

The meaning of attention-deficit/hyperactivity disorder medication and parents' initiation and continuity of treatment for their child.

Susan DosReis1, Matthew P Mychailyszyn, Sara E Evans-Lacko, Alicia Beltran, Anne W Riley, Mary Anne Myers.   

Abstract

OBJECTIVE: The aim of this study was to examine parents' early understanding of medication for attention-deficit/hyperactivity disorder (ADHD) in relation to decisions to initiate and continue treatment for their child.
METHODS: Qualitative, semistructured telephone interviews were conducted with 48 parents of children newly diagnosed with ADHD. Parents were recruited from inner city, outpatient primary care, and mental health clinics affiliated with a large university hospital. Data were analyzed using grounded theory.
RESULTS: Parents' initial perspectives of the appropriateness, anticipated effects, and symbolic meaning of medication were classified by four typologies (illness oriented, problem oriented, generally acceptable, unacceptable). In this sample, 29% of parents believed medication was required to treat the illness and 20% believed medication was unacceptable. Except for the unacceptable group, nearly all of the parents in the other groups initiated medication shortly after diagnosis. More than 80% of the illness- and problem-oriented groups used medication at 6 months; this fell to 64% and 78%, respectively, at 12 months. Only half of the unacceptable group ever used medication for their child.
CONCLUSIONS: Parents' views of ADHD medication may be predictive of continuity of treatment. Increasing physician awareness of parent preferences for managing their child's ADHD problems may lead to care management plans that maximize continuity.

Entities:  

Mesh:

Year:  2009        PMID: 19702489      PMCID: PMC2830211          DOI: 10.1089/cap.2008.0118

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  23 in total

1.  American attitudes toward and willingness to use psychiatric medications.

Authors:  Thomas W Croghan; Molly Tomlin; Bernice A Pescosolido; Jason Schnittker; Jack Martin; Keri Lubell; Ralph Swindle
Journal:  J Nerv Ment Dis       Date:  2003-03       Impact factor: 2.254

2.  Public attitudes toward the use of psychiatric medications for children.

Authors:  Jane D McLeod; Bernice A Pescosolido; David T Takeuchi; Terry Falkenberg White
Journal:  J Health Soc Behav       Date:  2004-03

3.  Parental knowledge of attention-deficit hyperactivity disorder and opinions of treatment options: impact on enrollment and adherence to a 12-month treatment trial.

Authors:  P Corkum; P Rimer; R Schachar
Journal:  Can J Psychiatry       Date:  1999-12       Impact factor: 4.356

4.  The effects of preparing parents for child psychotherapy on accuracy of expectations and treatment attendance.

Authors:  Amy L Shuman; Jeremy P Shapiro
Journal:  Community Ment Health J       Date:  2002-02

Review 5.  Parental attitudes and involvement in psychopharmacological treatment for ADHD: a conceptual model.

Authors:  Susan dosReis; Mary Anne Myers
Journal:  Int Rev Psychiatry       Date:  2008-04

6.  Assessing parents' willingness to pursue treatment for children with attention-deficit hyperactivity disorder.

Authors:  A L Rostain; T J Power; M S Atkins
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1993-01       Impact factor: 8.829

7.  Treatment expectancies, patient alliance, and outcome: further analyses from the National Institute of Mental Health Treatment of Depression Collaborative Research Program.

Authors:  Björn Meyer; Paul A Pilkonis; Janice L Krupnick; Matthew K Egan; Samuel J Simmens; Stuart M Sotsky
Journal:  J Consult Clin Psychol       Date:  2002-08

8.  Drug compliance and identity: reasons for non-compliance. Experiences of medication from persons with asthma/allergy.

Authors:  Marianne Hansson Scherman; Olle Löwhagen
Journal:  Patient Educ Couns       Date:  2004-07

9.  Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder.

Authors:  Susan Dosreis; Julie Magno Zito; Daniel J Safer; Karen L Soeken; John W Mitchell; Leslie C Ellwood
Journal:  J Dev Behav Pediatr       Date:  2003-06       Impact factor: 2.225

10.  When do patients and their physicians agree on diabetes treatment goals and strategies, and what difference does it make?

Authors:  Michele Heisler; Sandeep Vijan; Robert M Anderson; Peter A Ubel; Steven J Bernstein; Timothy P Hofer
Journal:  J Gen Intern Med       Date:  2003-11       Impact factor: 5.128

View more
  32 in total

1.  Using Best-Worst Scaling to Measure Caregiver Preferences for Managing their Child's ADHD: A Pilot Study.

Authors:  Susan dosReis; Xinyi Ng; Emily Frosch; Gloria Reeves; Charles Cunningham; John F P Bridges
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

2.  Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder.

Authors:  Daniel J Coletti; Elizabeth Pappadopulos; Nikki J Katsiotas; Alison Berest; Peter S Jensen; Vivian Kafantaris
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-04-26       Impact factor: 2.576

3.  A best-worst scaling experiment to prioritize caregiver concerns about ADHD medication for children.

Authors:  Melissa Ross; John F P Bridges; Xinyi Ng; Lauren D Wagner; Emily Frosch; Gloria Reeves; Susan dosReis
Journal:  Psychiatr Serv       Date:  2014-11-17       Impact factor: 3.084

Review 4.  Systematic Review of Patients' and Parents' Preferences for ADHD Treatment Options and Processes of Care.

Authors:  Nicole K Schatz; Gregory A Fabiano; Charles E Cunningham; Susan dosReis; Daniel A Waschbusch; Stephanie Jerome; Kellina Lupas; Karen L Morris
Journal:  Patient       Date:  2015-12       Impact factor: 3.883

Review 5.  Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.

Authors:  Jeffrey R Strawn; Eric T Dobson; Lisa L Giles
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2016-12-30

6.  Youth Views on Communication About ADHD and Medication Adherence.

Authors:  Betsy Sleath; Delesha M Carpenter; Robyn Sayner; Kathleen Thomas; Larry Mann; Adam Sage; Sandra H Sulzer; Adrian D Sandler
Journal:  Community Ment Health J       Date:  2017-01-10

7.  The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.

Authors:  Anton Pottegård; Bine Kjøller Bjerregaard; Dorte Glintborg; Lisbeth Sandal Kortegaard; Jesper Hallas; Søren Ilsøe Moreno
Journal:  Eur J Clin Pharmacol       Date:  2012-07-19       Impact factor: 2.953

8.  Here/In This Issue and There/Abstract Thinking: Does This Answer Your Question?

Authors:  Cynthia E Rogers
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2017-10       Impact factor: 8.829

9.  A Latent Class Analysis to Identify Variation in Caregivers' Preferences for their Child's Attention-Deficit/Hyperactivity Disorder Treatment: Do Stated Preferences Match Current Treatment?

Authors:  Xinyi Ng; John F P Bridges; Melissa M Ross; Emily Frosch; Gloria Reeves; Charles E Cunningham; Susan dosReis
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

Review 10.  Mental illness stigma, help seeking, and public health programs.

Authors:  Claire Henderson; Sara Evans-Lacko; Graham Thornicroft
Journal:  Am J Public Health       Date:  2013-03-14       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.